OTCMKTS:CPMV

Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

$0.31
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
$0.31
$0.31
50-Day Range
$0.31
$0.61
52-Week Range
$0.30
$1.05
Volume
N/A
Average Volume
443 shs
Market Capitalization
$2.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CPMV stock logo

About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV)

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

CPMV Stock Price History

CPMV Stock News Headlines

Mosaic ImmunoEngineering Inc Ordinary Shares CPMV
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
The Mosaic Co MOS
CPMV Mosaic ImmunoEngineering Inc.
Mosaic Unusual Options Activity For March 15
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic Immunoengineering Inc (CPMV)
See More Headlines
Receive CPMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/23/2024
Next Earnings (Estimated)
5/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:CPMV
Employees
4
Year Founded
N/A

Profitability

Net Income
$-1,010,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.81) per share

Miscellaneous

Free Float
1,377,000
Market Cap
$2.27 million
Optionable
Not Optionable
Beta
0.26
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Steven W. King (Age 60)
    Chairman of the Board, President & CEO
    Comp: $266.32k
  • Mr. Paul J. Lytle CPA (Age 56)
    Executive VP, CFO, Secretary & Director
    Comp: $291.65k
  • Jay Carlson
    Senior Manager of Investor Relations
  • Mr. Joseph S. Shan M.P.H. (Age 51)
    Head of Clinical Operations
  • Dr. Marvin R. Garovoy M.D. (Age 80)
    Head of Medical Immuno-Oncology
  • Cyril Empig Ph.D.
    Head of Vaccine Development

CPMV Stock Analysis - Frequently Asked Questions

How have CPMV shares performed in 2024?

Mosaic ImmunoEngineering's stock was trading at $0.60 at the start of the year. Since then, CPMV shares have decreased by 47.8% and is now trading at $0.3130.
View the best growth stocks for 2024 here
.

When is Mosaic ImmunoEngineering's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Sunday, May 12th 2024.
View our CPMV earnings forecast
.

How do I buy shares of Mosaic ImmunoEngineering?

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CPMV) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners